GT group (n = 18) | AH group (n = 18) | |
---|---|---|
Age (yr) | 74.39 (4.81) | 71.28 (7.84) |
Female (n%) | 14.0 (77.8) | 13.0 (72.2) |
Height | 160.06(9.12) | 162.21 (7.84) |
Weight | 62.61 (6.59) | 64.78 (12.96) |
BMI (kg/m2) | 24.74 (3.11) | 24.47 (3.41) |
Course of disease (yr) | 4.50 (4.32) | 4.17( 4.84) |
Bilateral/unilateral, n/n | 8/10 | 9/9 |
K-L grade, (n) | ||
II | 10 | 9 |
III | 7 | 8 |
IV | 1 | 1 |
Previous drug treatment, (n) | ||
Acetaminophen | 3 | 3 |
Nonsteroidal anti- inflammatory drugs | 2 | 3 |
Glucosamine or chondroitin products | 6 | 8 |